| 摘要 |
The present invention provides (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-cyclopropyl-1-{[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl) biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate, its salt, solvate, a crystalline form thereof, method for its production, a pharmaceutical agent comprising a compound of insulin sensitizer comprising the compound for preparing an angiotenzin antagonist II, medicinal agent for circulator diseases insulin sensitizer and intensifying hypoglycemic activity of the insulin sensitizer agent. |
